Showing results (281-290 of 542) with videos related to
Sort By:
Pageof 55
Clinical Colorectal Cancer|November 9, 2018
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center ExperienceKhurum Khan, Jayant K Rane, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junctionAndrew R Davies, James A Gossage, Janine Zylstra, et al.Journal of Pathology Informatics|February 23, 2023
Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slidesManon Beuque, Derek R Magee, Avishek Chatterjee, et al.NPJ Precision Oncology|January 13, 2026
Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trialTing Pu, Allyson M Peddle, Pratyaksha Wirapati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2021
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)Manish A Shah, Gyorgy Bodoky, Alexander Starodub, et al.Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.The New England Journal of Medicine|July 23, 2004
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancerDavid Cunningham, Yves Humblet, Salvatore Siena, et al.The New England Journal of Medicine|April 9, 2010
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancerJuan Valle, Harpreet Wasan, Daniel H Palmer, et al.BMC Cancer|February 18, 2016
Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective studySing Yu Moorcraft, Elisa Fontana, David Cunningham, et al.Nature Ecology & Evolution|May 21, 2021
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancerAndrew Woolston, Louise J Barber, Beatrice Griffiths, et al.Pageof 55